8-Azaguanine structure
|
Common Name | 8-Azaguanine | ||
|---|---|---|---|---|
| CAS Number | 134-58-7 | Molecular Weight | 152.114 | |
| Density | 2.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C4H4N6O | Melting Point | >300 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 129.1ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 8-Azaguanine8-Azaguanine is a purine analogue which shows antineoplastic activity. |
| Name | 8-azaguanine |
|---|---|
| Synonym | More Synonyms |
| Description | 8-Azaguanine is a purine analogue which shows antineoplastic activity. |
|---|---|
| Related Catalog | |
| In Vitro | 8-Azaguanine is a purine analogue which shows antineoplastic activity. The results show that cell viability decreases after incubation with 8-Azaguanine, in a dose and time dependent manner. After 24 h of treatment with 8-Azaguanine the IC50 for CEM cell line is about 100 μM while for MOLT3 cell line the IC50 is about 10 μM. CEM and MOLT3 cells surface expression of CD26 increases after treatment with 8-Azaguanine in a concentrations dependent manner[1]. |
| Cell Assay | Detection of apoptosis and necrosis is analyzed by Annexin V and propidium iodide staining. After incubation in the absence or in the presence of 8-Azaguanine, cells are washed (centrifuged at 300×g during 5 min) and incubated for 10 min at 4°C in 440 μL Annexin buffer, containing 5 μL Annexin V and 5 μL propidium iodide. Then cells are washed and re-suspended in phosphate buffered saline (PBS) until analysis[1]. |
| References |
| Density | 2.6±0.1 g/cm3 |
|---|---|
| Melting Point | >300 °C(lit.) |
| Molecular Formula | C4H4N6O |
| Molecular Weight | 152.114 |
| Flash Point | 129.1ºC |
| Exact Mass | 152.044662 |
| PSA | 113.34000 |
| LogP | -0.71 |
| Vapour Pressure | 0.00149mmHg at 25°C |
| Index of Refraction | 2.308 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | XZ6157000 |
| HS Code | 2933990090 |
|
~%
8-Azaguanine CAS#:134-58-7 |
| Literature: Gazzetta Chimica Italiana, , vol. 24 I, p. 481 - 498 C: MVol.D1, 24.9.4.2, page 290 - 290 |
|
~%
8-Azaguanine CAS#:134-58-7 |
| Literature: Ber. Dtsch. Chem. Ges., , vol. 45, p. 2731 - 2740 C: MVol.D1, 24.9.4.2, page 290 - 290 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
A Versatile Monoclonal Antibody Specific Against Human DAB2IP.
Monoclon. Antib. Immunodiagn. Immunother. 34 , 246-50, (2015) Human DAB2 interaction protein (DAB2IP) is a member of Ras-GTPase activating protein family and functions as a tumor suppressor, implying it could serve as a prognostic biomarker in cancers. Here we g... |
|
|
Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
Mol. Med. Report. 12 , 7712-20, (2015) A previous nationwide Chinese epidemiological study revealed through isolation of A‑B+ Clostridium difficile strains, which produce toxin B (TcdB), but not toxin A TcdA, that the strains are widesprea... |
|
|
Production and characterization of monospecific and bispecific antibodies against dengue virus NS1 protein.
J. Virol. Methods 220 , 5-12, (2015) Dengue is a mosquito borne infection, which in recent years has become a major international public health concern. Annually, 100 million dengue virus infections are reported worldwide. The nonstructu... |
| 2-Amino-6-hydroxy-8-azapurine,2-Amino-6-oxy-8-azapurine,8-AzaG |
| EINECS 205-148-1 |
| 8-Azaguanine |
| 7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one, 3,4,5,6-tetrahydro-5-imino- |
| MFCD00056937 |
| 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro- |
| 5-imino-3,4,5,6-tetrahydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one |
| 5-amino-2,3-dihydrotriazolo[4,5-d]pyrimidin-7-one |
| 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-1,6-dihydro- |
| 5-Amino-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one |
| 5-Amino-1,4-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one |